Vertex Pharmaceuticals ( VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic ...
Caprock Group LLC boosted its stake in shares of FedEx Co. (NYSE:FDX – Free Report) by 19.1% in the fourth quarter, according ...
Short FDX slightly under 265.57, target n/a, stop loss @ 266.34 Check the time stamp on this data. Updated AI-Generated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback